Hear first-hand from attendees on why the ISPE Annual Meeting & Expo is the must-attend pharmaceutical event of the year.
The 2018 ISPE Annual Meeting & Expo will focus on excellence, modernization, and harmonization in pharmaceutical science and manufacturing across the globe, offering pharma professionals the opportunity to engage in industry-critical conversations. A comprehensive education program provides attendees with technical sessions on the latest developments in:
Facilities & equipment
Product development & production systems
Quality systems & regulatory oversight
Cutting-edge industry innovations.
This signature event draws pharmaceutical and biopharmaceutical professionals at all levels of the industry from young professionals to the most senior executives in drug manufacturing, supply chain, devices and equipment and services, and global regulatory agencies. The conference offers a large exhibition hall offering the latest technologies and services for the pharmaceutical industry.
Two Days of Dynamic Training
Take advantage of the early registration discount for each course!
Join us after the 2018 ISPE Annual Meeting & Expo for an in-depth education experience on the following topics:
Raise your level of technical knowledge through peer-reviewed non-commercial education content from recognized experts in the field
Expand your professional network throughout the conference in educational sessions, the exhibit hall, and numerous special events
Enhance your individual and company’s recognition among industry colleagues through face-to-face interaction
Who Should Attend?
Professionals at all levels of the industry from young professionals to the most senior executives, Communities of Practice, special interest groups, pharmaceutical industry equipment and services suppliers, regulatory professionals
Nick Leschly has served as chief bluebird since September 2010. bluebird bio (BLUE) is a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies for cancer.
Lars Fruergaard Jørgensen joined Novo Nordisk in 1991 as an economist in Health Care, Economy & Planning and has over the years completed overseas postings in the Netherlands, the US and Japan. In 2004 he was appointed senior vice president for IT &
Kirsten Lund-Jurgensen, Ph.D., is the Executive Vice President and President, Pfizer Global Supply (PGS). She is responsible for Pfizer’s internal and external manufacturing and supply network. Throughout her 30-year pharmaceutical industry career, s
Phil is a global ambassador for diabetes and is committed to educating and empowering people with diabetes across the world. Born in Florida, USA in 1982, he was diagnosed with type 1 diabetes at just seven months old when doctors told his mother he